Concepedia

Siddha Kasar

SK

Statistics

Publications

20

Citations

1.6K

H-Index

16

Active since

2011

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Massachusetts General Hospital

Broad Institute

Siddha Kasar is an author at Dana-Farber Cancer Institute specializing in life sciences, molecular oncology, and oncology.

Publications per year

2011–2021

20

Publications

20

Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity

Benjamin L. Lampson, Siddha Kasar, Tiago R. Matos et al. · Blood · 2016 · 289 citations · Full text

Pharmacy, Oncology, Pharmacology +8

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution

Siddha Kasar, Jaegil Kim, Reina Improgo et al. · Nature Communications · 2015 · 275 citations · Full text

Life Sciences, Genetics, Oncology +17

Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia

Christopher J. Ott, Alexander Federation, Logan S. Schwartz et al. · Cancer Cell · 2018 · 174 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +16

Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells

Mara Compagno, Qi Wang, Chiara Pighi et al. · Nature · 2017 · 123 citations · Full text

Life Sciences, Immunology, Molecular Biology +12

TLR7 and TLR8 Differentially Activate the IRF and NF-κB Pathways in Specific Cell Types to Promote Inflammation

Andrew T. Bender, Evgeni P. Tzvetkov, Albertina Pereira et al. · ImmunoHorizons · 2020 · 118 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

1–5 of 20